D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Apple
AAPL
|
+$315M |
| 2 |
Exxon Mobil
XOM
|
+$312M |
| 3 |
Verizon
VZ
|
+$289M |
| 4 |
Procter & Gamble
PG
|
+$288M |
| 5 |
Pfizer
PFE
|
+$272M |
Top Sells
| 1 |
Tesla
TSLA
|
+$619M |
| 2 |
Biogen
BIIB
|
+$369M |
| 3 |
Amazon
AMZN
|
+$341M |
| 4 |
Netflix
NFLX
|
+$309M |
| 5 |
Emerson Electric
EMR
|
+$306M |
Sector Composition
| 1 | Technology | 23.54% |
| 2 | Healthcare | 14.5% |
| 3 | Consumer Discretionary | 11.23% |
| 4 | Financials | 9.56% |
| 5 | Communication Services | 7.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2301
Chord Energy
CHRD
$6.1B
| $251K | ﹤0.01% |
716,553
-3,710,510
| -84% | -$1.3M |
|
2302
New Mountain Finance
NMFC
$1.11B
| $251K | ﹤0.01% |
36,892
-107,302
| -74% | -$730K |
|
2303
Taylor Morrison
TMHC
$6.89B
| $251K | ﹤0.01% |
22,800
-145,753
| -86% | -$1.6M |
|
2304
Badger Meter
BMI
$5.23B
| $249K | ﹤0.01% |
4,649
-106
| -2% | -$5.68K |
|
|
CVET
2305
DELISTED
Covetrus, Inc. Common Stock
CVET
| $248K | ﹤0.01% |
30,497
+2,696
| +10% | +$21.9K |
|
|
CNCE
2306
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $247K | ﹤0.01% |
27,932
-12,499
| -31% | -$111K |
|
2307
Tompkins Financial
TMP
$998M
| $246K | ﹤0.01% |
+3,431
| New | +$246K |
|
2308
Afya
AFYA
$1.38B
| $244K | ﹤0.01% |
12,788
-111
| -0.9% | -$2.12K |
|
2309
Boot Barn
BOOT
$5.61B
| $244K | ﹤0.01% |
+18,899
| New | +$244K |
|
|
ESGR
2310
DELISTED
Enstar Group
ESGR
| $244K | ﹤0.01% |
1,537
+33
| +2% | +$5.24K |
|
2311
Ameriprise Financial
AMP
$46.4B
| $243K | ﹤0.01% |
+2,368
| New | +$243K |
|
|
BCPC
2312
Balchem Corporation
BCPC
$5.05B
| $243K | ﹤0.01% |
2,466
-11,395
| -82% | -$1.12M |
|
2313
First Citizens BancShares
FCNCA
$25.2B
| $242K | ﹤0.01% |
727
-6,528
| -90% | -$2.17M |
|
2314
Helios Technologies
HLIO
$1.82B
| $242K | ﹤0.01% |
6,387
-3,667
| -36% | -$139K |
|
|
EVV
2315
Eaton Vance Limited Duration Income Fund
EVV
$1.2B
| $238K | ﹤0.01% |
+22,500
| New | +$238K |
|
2316
Rithm Capital
RITM
$6.63B
| $238K | ﹤0.01% |
47,530
-534,969
| -92% | -$2.68M |
|
2317
ResMed
RMD
$39.6B
| $238K | ﹤0.01% |
1,614
+200
| +14% | +$29.5K |
|
2318
Haverty Furniture Companies
HVT
$380M
| $237K | ﹤0.01% |
19,896
-16,748
| -46% | -$200K |
|
2319
Shenandoah Telecom
SHEN
$728M
| $237K | ﹤0.01% |
4,813
-14,896
| -76% | -$734K |
|
|
BRSP
2320
BrightSpire Capital
BRSP
$767M
| $233K | ﹤0.01% |
+59,226
| New | +$233K |
|
2321
Future Fuel
FF
$171M
| $233K | ﹤0.01% |
20,663
+3,428
| +20% | +$38.7K |
|
2322
MGP Ingredients
MGPI
$588M
| $233K | ﹤0.01% |
8,671
-141,476
| -94% | -$3.8M |
|
|
PHK
2323
PIMCO High Income Fund
PHK
$856M
| $233K | ﹤0.01% |
+47,500
| New | +$233K |
|
|
CLVS
2324
DELISTED
Clovis Oncology, Inc.
CLVS
| $233K | ﹤0.01% |
36,567
-389,964
| -91% | -$2.48M |
|
2325
Cyclerion Therapeutics
CYCN
$7.57M
| $231K | ﹤0.01% |
4,355
-9,284
| -68% | -$492K |
|